DUBLIN, April 26, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it has reached definitive agreements to acquire Somerset Therapeutics, LLC, a New Jersey based specialty pharmaceutical company that develops and markets sterile injectable and ophthalmic drug...
from PR Newswire: //https://ift.tt/2HzfwxD
No comments:
Post a Comment